盛視科技(002990.SZ):天府機場項目已簽約 合同價4.08億元
格隆匯12月21日丨盛視科技(002990.SZ)公佈,近日,公司成功中標成都天府國際機場口岸檢查檢驗及配套設備設施項目(航站樓現場部分)(簡稱“天府機場項目”),並已取得項目中標通知書。
公司於2020年12月17日召開的第二屆董事會第十六次會議審議通過了《關於簽署成都天府國際機場口岸檢查檢驗及配套設備設施項目(航站樓現場部分)合同書的議案》,同意公司簽署天府機場項目合同書。
截至2020年12月21日,該項目合同已簽署完成。簽約合同價約4.08億元,佔公司2019年度經審計主營業務收入的50.55%;項目工期為142天。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.